Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Financial Information Relating to Reportable Segments (Details)

v3.24.0.1
Segment Information - Financial Information Relating to Reportable Segments (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]        
Revenues, net $ 272,598 $ 271,581 $ 549,533 $ 541,236
Operating income 38,004 67,891 93,866 124,208
Costs recognized on sale of acquired inventory     (364) (400)
Impact of partially-owned consolidated subsidiaries       (179)
Restructuring and restructuring-related costs (11,424)   (11,424)  
Corporate general, selling, and administrative expenses (115,667) (93,010) (220,998) (192,386)
Protein Sciences        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Restructuring and restructuring-related costs     (9,460)  
Diagnostics and Genomics        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Restructuring and restructuring-related costs     (739)  
Operating Segments        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Operating income 84,142 97,632 173,029 192,212
Costs recognized on sale of acquired inventory (183) (100) (364) (400)
Amortization of intangibles (19,769) (19,125) (39,620) (38,408)
Impact of partially-owned consolidated subsidiaries(1)       647
Acquisition related expenses and other 525 8,307 1,114 8,010
Impairment of assets held-for-sale (6,038)   (6,038)  
Stock based compensation, inclusive of employer taxes (12,958) (16,878) (24,453) (32,336)
Restructuring and restructuring-related costs (5,518) (780) (5,607) (2,950)
Corporate general, selling, and administrative expenses (2,197) (1,165) (4,195) (2,567)
Operating Segments | Protein Sciences        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Revenues, net 197,670 203,887 402,325 403,836
Operating income 79,586 89,336 167,947 175,278
Operating Segments | Diagnostics and Genomics        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Revenues, net 75,408 68,003 148,204 137,907
Operating income 4,556 8,296 5,082 16,934
Intersegment Eliminations        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Revenues, net $ (480) $ (309) $ (996) $ (507)